跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,692 条关于
“Hangzhou Qihan Biotech Co., Ltd.”
全部
21,692
临床试验
4,389
药物
2,541
机构
4,546
资讯
10,216
去年
First-in-Human iPSC-CAR-NK Cell Therapy Shows Promise for Autoimmune Disease Treatment
去年
Qihan Biotech Receives FDA Clearance for QT-019B, First Universal Dual-Target CAR-T Therapy for Refractory Lupus
去年
Qihan Biotech Unveils Novel Cytokine Pathway Engineering for Enhanced CAR-T Therapy Without Lymphodepletion
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
3个月前
Qihan Biotech Receives FDA IND Clearance for QT-019C Universal CAR-T Therapy Targeting Autoimmune Diseases
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
去年
Rege Nephro Secures $150 Million in Series B Funding to Advance Kidney Disease Therapies
去年
Lumosa Therapeutics' LT3001 Shows Promise in Phase II Acute Ischemic Stroke Trial
9个月前
Qihan Biotech Initiates Phase I/IIa Trial of Off-the-Shelf CAR-T Therapy for Refractory Lupus
去年
Dizal Submits NDA to FDA for Sunvozertinib in EGFR Exon20ins NSCLC
第 1 页，共 1022 页
上一页
下一页
